REZOLUTE INC (RZLT) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:RZLT • US76200L3096

2.945 USD
+0.03 (+1.2%)
Last: Feb 5, 2026, 03:46 PM
Fundamental Rating

3

Overall RZLT gets a fundamental rating of 3 out of 10. We evaluated RZLT against 524 industry peers in the Biotechnology industry. RZLT has a great financial health rating, but its profitability evaluates not so good. RZLT is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year RZLT has reported negative net income.
  • RZLT had a negative operating cash flow in the past year.
  • RZLT had negative earnings in each of the past 5 years.
  • RZLT had a negative operating cash flow in each of the past 5 years.
RZLT Yearly Net Income VS EBIT VS OCF VS FCFRZLT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -20M -40M -60M

1.2 Ratios

  • RZLT has a Return On Assets (-48.82%) which is in line with its industry peers.
  • The Return On Equity of RZLT (-52.63%) is better than 65.65% of its industry peers.
Industry RankSector Rank
ROA -48.82%
ROE -52.63%
ROIC N/A
ROA(3y)-45.28%
ROA(5y)-42.37%
ROE(3y)-49.01%
ROE(5y)-50.92%
ROIC(3y)N/A
ROIC(5y)N/A
RZLT Yearly ROA, ROE, ROICRZLT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2K 4K 6K

1.3 Margins

  • RZLT does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
RZLT Yearly Profit, Operating, Gross MarginsRZLT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. Health

2.1 Basic Checks

  • Compared to 1 year ago, RZLT has more shares outstanding
  • Compared to 5 years ago, RZLT has more shares outstanding
  • There is no outstanding debt for RZLT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
RZLT Yearly Shares OutstandingRZLT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
RZLT Yearly Total Debt VS Total AssetsRZLT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

2.2 Solvency

  • An Altman-Z score of 9.73 indicates that RZLT is not in any danger for bankruptcy at the moment.
  • With an excellent Altman-Z score value of 9.73, RZLT belongs to the best of the industry, outperforming 81.87% of the companies in the same industry.
  • There is no outstanding debt for RZLT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 9.73
ROIC/WACCN/A
WACCN/A
RZLT Yearly LT Debt VS Equity VS FCFRZLT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M 150M

2.3 Liquidity

  • RZLT has a Current Ratio of 15.15. This indicates that RZLT is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of RZLT (15.15) is better than 91.98% of its industry peers.
  • A Quick Ratio of 15.15 indicates that RZLT has no problem at all paying its short term obligations.
  • RZLT's Quick ratio of 15.15 is amongst the best of the industry. RZLT outperforms 91.98% of its industry peers.
Industry RankSector Rank
Current Ratio 15.15
Quick Ratio 15.15
RZLT Yearly Current Assets VS Current LiabilitesRZLT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 26.77% over the past year.
EPS 1Y (TTM)26.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%18.18%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • The Earnings Per Share is expected to grow by 25.99% on average over the next years. This is a very strong growth
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y26.39%
EPS Next 2Y13.68%
EPS Next 3Y18.24%
EPS Next 5Y25.99%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
RZLT Yearly Revenue VS EstimatesRZLT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2027 2028 2029 2030 2031 2032 2033 100M 200M 300M 400M
RZLT Yearly EPS VS EstimatesRZLT Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 -5 -10 -15

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for RZLT. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for RZLT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RZLT Price Earnings VS Forward Price EarningsRZLT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
RZLT Per share dataRZLT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 1.5

4.3 Compensation for Growth

  • RZLT's earnings are expected to grow with 18.24% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y13.68%
EPS Next 3Y18.24%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • RZLT does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

REZOLUTE INC

NASDAQ:RZLT (2/5/2026, 3:46:09 PM)

2.945

+0.03 (+1.2%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-06
Earnings (Next)02-10
Inst Owners109.4%
Inst Owner Change0.64%
Ins Owners1.52%
Ins Owner Change0.78%
Market Cap273.09M
Revenue(TTM)N/A
Net Income(TTM)-77.45M
Analysts80
Price Target6.38 (116.64%)
Short Float %22.77%
Short Ratio2.33
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)8.77%
Min EPS beat(2)-15.86%
Max EPS beat(2)33.41%
EPS beat(4)2
Avg EPS beat(4)2.85%
Min EPS beat(4)-18.3%
Max EPS beat(4)33.41%
EPS beat(8)4
Avg EPS beat(8)2.09%
EPS beat(12)8
Avg EPS beat(12)6.04%
EPS beat(16)11
Avg EPS beat(16)9.34%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.04%
PT rev (3m)-55.36%
EPS NQ rev (1m)0.53%
EPS NQ rev (3m)32.81%
EPS NY rev (1m)2.23%
EPS NY rev (3m)37.06%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.86
P/tB 1.86
EV/EBITDA N/A
EPS(TTM)-0.93
EYN/A
EPS(NY)-0.69
Fwd EYN/A
FCF(TTM)-0.76
FCFYN/A
OCF(TTM)-0.76
OCFYN/A
SpS0
BVpS1.59
TBVpS1.59
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -48.82%
ROE -52.63%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-45.28%
ROA(5y)-42.37%
ROE(3y)-49.01%
ROE(5y)-50.92%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 15.15
Quick Ratio 15.15
Altman-Z 9.73
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)26.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%18.18%
EPS Next Y26.39%
EPS Next 2Y13.68%
EPS Next 3Y18.24%
EPS Next 5Y25.99%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-16.15%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-48.24%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-48.49%
OCF growth 3YN/A
OCF growth 5YN/A

REZOLUTE INC / RZLT FAQ

What is the fundamental rating for RZLT stock?

ChartMill assigns a fundamental rating of 3 / 10 to RZLT.


Can you provide the valuation status for REZOLUTE INC?

ChartMill assigns a valuation rating of 0 / 10 to REZOLUTE INC (RZLT). This can be considered as Overvalued.


What is the profitability of RZLT stock?

REZOLUTE INC (RZLT) has a profitability rating of 1 / 10.


What is the earnings growth outlook for REZOLUTE INC?

The Earnings per Share (EPS) of REZOLUTE INC (RZLT) is expected to grow by 26.39% in the next year.


Can you provide the dividend sustainability for RZLT stock?

The dividend rating of REZOLUTE INC (RZLT) is 0 / 10 and the dividend payout ratio is 0%.